Drugs and Devices

FDA approves injection for type 2 diabetes

On July 28, the Food and Drug Administration (FDA) approved Adlyxin (lixisenatide), a once-daily injection to improve glycemic control, along with diet and exercise, in adults with type 2 diabetes. Read more


Related Articles:

Leave a Reply

You have to agree to the comment policy.

 

Shares